![Sasha Cucuz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/05/2026
Mr. Sasha Cucuz is an Independent Director at NeuPath Health, Inc., a Chief Executive Officer at Greybrook Securities, Inc., an Executive Vice President at TMS NeuroHealth Centers Tysons Corner LLC and a Principal at Greybrook Health, Inc. He is on the Board of Directors at Neuronetics, Inc., NeuPath Health, Inc., Blu Genes Foundation, Delos Canada, Inc., Greysprings Apartments and The Greybrook Montreal-QC Value-Add Trust.
Mr. Cucuz was previously employed as a Chairman by Greenbrook TMS, Inc., a Principal by CIBC Capital Partners, a Founder by Greybrook Corp., a Principal by TD Securities, Inc., and a Director & Executive Vice President by TMS NeuroHealth Centers, Inc. He also served on the board at Klinik Health Ventures Corp.
He received his undergraduate degree from York University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NEURONETICS, INC. 3,12 % | 28/05/2026 | 2.060.924 ( 3,12 % ) | 3 M $ | 31/05/2026 |
NEUPATH HEALTH INC. 0,17 % | 15/06/2026 | 93.118 ( 0,17 % ) | 39 855 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUPATH HEALTH INC. | Director/Miembro de la Junta | 25/06/2020 |
| NEURONETICS, INC. | Director/Miembro de la Junta | 10/12/2024 |
Greybrook Health, Inc.
 Greybrook Health, Inc. Investment ManagersFinance Greybrook Healthcare is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of medical device and healthcare services companies. It provides financing for growth stage capital requirements. | Inversor de Capital Privado | - |
TMS NeuroHealth Centers Tysons Corner LLC
 TMS NeuroHealth Centers Tysons Corner LLC Medical/Nursing ServicesHealth Services Provides treatment for depressive disorder and other neurological diseases | Fundador | 01/01/2011 |
Greybrook Securities, Inc. | Director Ejecutivo | 01/01/2005 |
Blu Genes Foundation
 Blu Genes Foundation Miscellaneous Commercial ServicesCommercial Services Blu Genes Foundation is a charitable organization dedicated to advancing gene therapy research aimed at finding cures and treatments for rare and ultra-rare genetic disorders, including Tay-Sachs disease, Pelizaeus-Merzbacher-like disease (PMLD), and hereditary spastic paraplegia type 4 (SPG4). The private company is based in Toronto, Canada. The foundation partners with research institutions such as SickKids Hospital and the University of Massachusetts Medical School to support gene editing and gene therapy studies, including CRISPR/Cas9 technology and AAV-mediated gene delivery. It funds clinical trials and develops therapies targeting these disorders, engages the community by sharing personal stories, and organizes annual fundraising events to support research. | Director/Miembro de la Junta | - |
The Greybrook Montreal-QC Value-Add Trust
 The Greybrook Montreal-QC Value-Add Trust Real Estate DevelopmentFinance Provides real estate services | Director/Miembro de la Junta | - |
Delos Canada | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GREENBROOK TMS INC. | Presidente | 09/12/2024 |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
TMS NeuroHealth Centers Tysons Corner LLC
TMS NeuroHealth Centers Tysons Corner LLC Medical/Nursing ServicesHealth Services Provides treatment for depressive disorder and other neurological diseases | Health Services |
TD Securities, Inc.
 TD Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CIBC Capital Partners
 CIBC Capital Partners Investment ManagersFinance Alternative investment manager | Finance |
Greybrook Health, Inc.
Greybrook Health, Inc. Investment ManagersFinance Greybrook Healthcare is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of medical device and healthcare services companies. It provides financing for growth stage capital requirements. | Finance |
TMS NeuroHealth Centers, Inc.
 TMS NeuroHealth Centers, Inc. Medical/Nursing ServicesHealth Services Provides depressive disorder treatments | Health Services |
Greybrook Corp.
 Greybrook Corp. Investment ManagersFinance Provides real estate investment and asset management services | Finance |
Greenbrook TMS, Inc.
 Greenbrook TMS, Inc. Medical/Nursing ServicesHealth Services Provides transcranial magnetic stimulation therapy services for treatment of major depressive and mental health disorders | Health Services |
Greybrook Securities, Inc. | |
The Greybrook Montreal-QC Value-Add Trust
The Greybrook Montreal-QC Value-Add Trust Real Estate DevelopmentFinance Provides real estate services | Finance |
Blu Genes Foundation
Blu Genes Foundation Miscellaneous Commercial ServicesCommercial Services Blu Genes Foundation is a charitable organization dedicated to advancing gene therapy research aimed at finding cures and treatments for rare and ultra-rare genetic disorders, including Tay-Sachs disease, Pelizaeus-Merzbacher-like disease (PMLD), and hereditary spastic paraplegia type 4 (SPG4). The private company is based in Toronto, Canada. The foundation partners with research institutions such as SickKids Hospital and the University of Massachusetts Medical School to support gene editing and gene therapy studies, including CRISPR/Cas9 technology and AAV-mediated gene delivery. It funds clinical trials and develops therapies targeting these disorders, engages the community by sharing personal stories, and organizes annual fundraising events to support research. | Commercial Services |
Klinik Health Ventures Corp.
 Klinik Health Ventures Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NeuPath Health, Inc.
 NeuPath Health, Inc. Financial ConglomeratesFinance Provides chronic pain management services | Finance |
Delos Canada |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
